Vanrafia: payments to doctors
Payments that named Vanrafia as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $380K
- Providers
- 2,663
- Transactions
- 5,486
- Average per transaction
- $69
The per-transaction average — $69 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 2,663 providers the average total is $143, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Novartis | $378,137 | 99.4% |
| Novartis Pharma AG | $2,275 | 0.6% |